Ramón TM, Ugarte SJC, Ugarte MD, Piñera MJ, González NJ

Language: Spanish
References: 16
Page: 163-173
PDF size: 446.61 Kb.

ABSTRACT

Introduction. Osteoporosis is a decrease of the bone mass and cause susceptibility for the fractures. Methods. We made a descriptive observational study of longitudinal court, with the objective of obtaining the densitometric pattern in patient submitted to hemodialysis for renal failure, in the hospital CIMEQ, in two years. The universe formed by 25 patients in dialysis plan. Results. The groups of ages prevailed among 30 at 39 and 50 to 59 years, for 28%. There was prevalence of male (76%), and black (56%). Secondary nephropathies contributed the biggest number of cases as main etiology, occupying 64%. We compared densities changes at 6 and 18 months, of staying in the plan. We analyzing the results with the serum levels of Ca and P. The evolutive densitometric studies detect positive growing results, associated to improvements in the levels of Ca and P in blood. Conclusions. At the end of the study 84% of the total of the sample had a normal densitometry, and only 16% osteopenia.

REFERENCES

1. Acebes Cachafeiro JC, Herrero Beaumont G. Osteoporosis: prevención y tratamiento. Soc Española de Reumat.1997;164:1-23.

2. Sit D, Kadiroglu AK, Kayabasi H. Relation between bone mineral density and biochemical markers of bone turnover in hemodialysis patients. Adv Ther. 2007; 24(5):987- 95.

3. Garay Lillo J, Perreño J, González JA. Estudio prospectivo sobre el riesgo de fracturas en mujeres ancianas. Geriatría.1997;13:16-19.

4. Collantes E, Rodríguez M. Fisiopatología del metabolismo fosfocálcico. Soc Española de Reumat. 2002;642:31-35.

5. Farrarons J, Vallas LLobet C. Es eficaz la vitamina D en el tratamiento de la osteoporosis si se administra sin sales de calcio. Edika Med. 1998; 12:186-92.

6. Stevenson JC, Lindsay R. Osteoporosis. Ed. C Hapman and Hall Medical. London; 1998.

7. Sociedad Argentina de Osteoporosis. Guía para la comunidad; 2006.

8. Favus MJ. Metabolic Bone Diseases and Disorders of Mineral Metabolism. Ed. Philadelphia.EU;1999.

9. Cummings SR. Factores de riesgo de fracturas comparadas con masa ósea. Proccedings of the 1996 World Congress on Osteoporosis. Amsterdam1996;2:108-12.

10. Jaramilo N. Creciente uso mundial de la densitometría ósea. Lunar News-Lunar Corporation. 2002;4: 2-6.

11. Laustaled R. Tratamiento de la osteoporosis. Edika Med.1998;6:103-14.

12. Rodríguez de la Serna A. Osteoporosis. Prevención y Tratamiento. Soc Española de Reumat.1997; 30:109–17.

13. Soriano A, Uribarri G. Métodos de determinación de la masa ósea: Osteoporosis. Rev Esp Med Nuclear. 1989;(3):47-52.

14. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long term haemodialysis patients: a meta analysis. Am J Kidney Dis. 2007;49(5):674-81.

15. Jamal SA. Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hipertens. 2010;19(4):343-48.

16. Orlic L, Crncevic Z, Pavlovic D, Zaputovic L. Bone mineral densitometry in patients on haemodialysis: difference between genders and what to measure. Ren Fail. 2010;32(3):300-8.